| Lung Diagnosis Group | Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | |
| Total | 3,400 | 3,716 | 4,157 | 4,487 | 4,853 | 5,298 | 5,852 | 6,386 | 6,731 |
| Group A: Obstructive Lung Disease | 1,868 | 2,048 | 2,328 | 2,473 | 2,636 | 2,796 | 2,969 | 3,098 | 3,127 |
| Group B: Pulmonary Vascular Disease | 245 | 247 | 247 | 249 | 266 | 273 | 289 | 307 | 311 |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 606 | 687 | 750 | 807 | 851 | 940 | 1,017 | 1,118 | 1,156 |
| Group D: Restrictive Lung Disease | 531 | 580 | 672 | 788 | 927 | 1,105 | 1,390 | 1,667 | 1,945 |
| Group E: Age Less Than 12 | 86 | 88 | 90 | 101 | 102 | 106 | 110 | 120 | 113 |
| Other Diagnosis | 64 | 66 | 70 | 69 | 71 | 78 | 77 | 76 | 79 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Group A: Obstructive Lung Disease | 54.9% | 55.1% | 56.0% | 55.1% | 54.3% | 52.8% | 50.7% | 48.5% | 46.5% |
| Group B: Pulmonary Vascular Disease | 7.2% | 6.6% | 5.9% | 5.5% | 5.5% | 5.2% | 4.9% | 4.8% | 4.6% |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 17.8% | 18.5% | 18.0% | 18.0% | 17.5% | 17.7% | 17.4% | 17.5% | 17.2% |
| Group D: Restrictive Lung Disease | 15.6% | 15.6% | 16.2% | 17.6% | 19.1% | 20.9% | 23.8% | 26.1% | 28.9% |
| Group E: Age Less Than 12 | 2.5% | 2.4% | 2.2% | 2.3% | 2.1% | 2.0% | 1.9% | 1.9% | 1.7% |
| Other Diagnosis | 1.9% | 1.8% | 1.7% | 1.5% | 1.5% | 1.5% | 1.3% | 1.2% | 1.2% |